Evidence map›Paper›PMID 37954426›Full record

ArticleRSC advances2023

Study on the chemical reactivity difference of primary hydroxyl groups in iridoid glycosides.

Yuanfang Kong, Jindan Xu, Pengbo Zhu, Shaopei Wang, Bin Yang, Jingyu Zhang, Chunhong Dong

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuanfang KongHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.ORCID https://orcid.org/0000-0002-9220-4275
Jindan XuHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
Pengbo ZhuHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
Shaopei WangHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
Bin YangHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
Jingyu ZhangHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
Chunhong DongHenan University of Chinese Medicine Zhengzhou 450046 Henan China kongyf@hactcm.edu.cn jyzhang2004@126.com chunhong_dong@hactcm.edu.cn.
First Affiliated Hospital of Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iridoid glycoside, which belongs to the polyhydroxy compound, is a kind of active ingredient of traditional Chinese medicine with a wide range of sources, and has many pharmacological effects such as anti-cancer, anti-inflammatory, anti-virus, hypoglycemic and so on. Its structure contains many hydroxyl groups, including two primary hydroxyl groups. The chemical reactivity of primary hydroxyl groups has very little difference, so it is very important to control the selectivity of hydroxyl groups under certain conditions. In this paper, the difference between the two primary hydroxyl groups in iridoid glycoside was calculated based on computer simulation and verified this result through designed experiments. This study will provide an important way for site-directed modification of hydroxyl in iridoid glycoside in the future.

Identifiers

PMID37954426
PMCPMC10637112
OpenAlexW4388567010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.